355 related articles for article (PubMed ID: 25646018)
41. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
[TBL] [Abstract][Full Text] [Related]
42. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
43. Curcumin prevents adriamycin nephrotoxicity in rats.
Venkatesan N; Punithavathi D; Arumugam V
Br J Pharmacol; 2000 Jan; 129(2):231-4. PubMed ID: 10694226
[TBL] [Abstract][Full Text] [Related]
44. Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease.
Maimaitiyiming H; Zhou Q; Wang S
PLoS One; 2016; 11(5):e0156144. PubMed ID: 27196103
[TBL] [Abstract][Full Text] [Related]
45. Selenium-mediated cardioprotection against adriamycin-induced mitochondrial damage.
Dursun N; Taşkın E; Yerer Aycan MB; Sahin L
Drug Chem Toxicol; 2011 Apr; 34(2):199-207. PubMed ID: 21314470
[TBL] [Abstract][Full Text] [Related]
46. Mesenchymal stem cells protective effect in adriamycin model of nephropathy.
Magnasco A; Corselli M; Bertelli R; Ibatici A; Peresi M; Gaggero G; Cappiello V; Chiavarina B; Mattioli G; Gusmano R; Ravetti JL; Frassoni F; Ghiggeri GM
Cell Transplant; 2008; 17(10-11):1157-67. PubMed ID: 19181210
[TBL] [Abstract][Full Text] [Related]
47. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ.
Zhu C; Huang S; Yuan Y; Ding G; Chen R; Liu B; Yang T; Zhang A
Am J Pathol; 2011 May; 178(5):2020-31. PubMed ID: 21514419
[TBL] [Abstract][Full Text] [Related]
48. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
49. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
Liao R; Liu Q; Zheng Z; Fan J; Peng W; Kong Q; He H; Yang S; Chen W; Tang X; Yu X
PLoS One; 2015; 10(7):e0132724. PubMed ID: 26161538
[TBL] [Abstract][Full Text] [Related]
50. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
51. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction.
Guo Y; Deng X; Chen S; Yang L; Ni J; Wang R; Lin J; Bai M; Jia Z; Huang S; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F589-F598. PubMed ID: 27974319
[TBL] [Abstract][Full Text] [Related]
53. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
54. Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes.
He FF; Zhang C; Chen S; Deng BQ; Wang H; Shao N; Tian XJ; Fang Z; Sun XF; Liu JS; Zhu ZH; Meng XF
Cell Biol Int; 2011 Aug; 35(8):827-34. PubMed ID: 21166652
[TBL] [Abstract][Full Text] [Related]
55. Protein Kinase A/CREB Signaling Prevents Adriamycin-Induced Podocyte Apoptosis via Upregulation of Mitochondrial Respiratory Chain Complexes.
Xie K; Zhu M; Xiang P; Chen X; Kasimumali A; Lu R; Wang Q; Mou S; Ni Z; Gu L; Pang H
Mol Cell Biol; 2018 Jan; 38(1):. PubMed ID: 29038164
[TBL] [Abstract][Full Text] [Related]
56. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
[TBL] [Abstract][Full Text] [Related]
57. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
[TBL] [Abstract][Full Text] [Related]
58. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
Zhang X; Qu X; Sun YB; Caruana G; Bertram JF; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(6):e67471. PubMed ID: 23840712
[TBL] [Abstract][Full Text] [Related]
59. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
Wang Z; Bao H; Ge Y; Zhuang S; Peng A; Gong R
Br J Pharmacol; 2015 Feb; 172(3):895-909. PubMed ID: 25262943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
